Skip to main content

riociguat

Generic: RIOCIGUAT·Brand: ADEMPAS, Adempas, RIOCIGUAT

riociguat: 1 clinical trial tracked.

riociguat evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about riociguat, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (1)

An Open-label, Prospective, Single Centre Study of the Effects of Riociguat on RIght VEntricular Size and Function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

NCT04954742Registry updated 2026-06-17·Phase 4
Terminated

Primary endpoint: Change in RV (Right Ventricular) Area

Interventionalopen30 targetStarted 2022-04Completion 2025-081 site · GermanyHeidelberg University